How effective is Angeliq for Hormone Replacement Therapy? (a real world drug study)

Summary:

Overall ratings: 2.7/5
Long term ratings: 3.5/5

This is a phase IV clinical study of how effective Angeliq (drospirenone; estradiol) is for Hormone replacement therapy and for what kind of people. The study is created by eHealthMe from 7 Angeliq users and is updated continuously.

What is Angeliq?

Angeliq has active ingredients of drospirenone; estradiol. It is often used in menopause. eHealthMe is studying from 632 Angeliq users. Check the latest studies of Angeliq.

What is Hormone replacement therapy?

Hormone replacement therapy is found to be associated with 11 drugs and 98 conditions by eHealthMe. Check the latest studies of Hormone replacement therapy.


On Jul, 12, 2026

7 people are studied for taking Angeliq in Hormone replacement therapy

Overall effectiveness (number of people):

Does Angeliq work for your Hormone replacement therapy (overall)?

Long term (1+ years) effectiveness (number of people):

Does Angeliq work for your Hormone replacement therapy (long term)?

Angeliq effectiveness for Hormone replacement therapy (number of people):

Overall:
  • not at all: 1
  • somewhat: 2
  • moderate: 2
  • high: 2
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 1
  • high: 1
  • very high: 0

Gender of people who take Angeliq for Hormone replacement therapy *:

  • female: 85.71 %
  • male: 14.29 %

Age of people who take Angeliq for Hormone replacement therapy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 14.29 %
  • 50-59: 85.71 %
  • 60+: 0.0 %

Who find Angeliq more effective for Hormone Replacement Therapy?

Gender of people who take Angeliq for Hormone replacement therapy *:

  • female: 50 %
  • male: 50 %

Age of people who take Angeliq for Hormone replacement therapy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 50 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Angeliq?

- You can start a phase IV clinical trial to monitor Angeliq safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on drospirenone; estradiol (the active ingredients of Angeliq) and Angeliq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: